lunes, 17 de agosto de 2026
Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start By Angela Hart Aug. 17, 2026
https://kffhealthnews.org/health-care-costs/gavin-newsom-calrx-state-branded-insulin-generic-biosimilar-drugs-rollout/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8azsjfLu5hqwm2tg_EGLIZgFJb9dUhRWDfsCZF9D4I36Jk0fVPPZinCl9VIlAwr-CWCN6MuUsAoP91jE2GIQJKRFi1_w&_hsmi=433530189&utm_content=433530189&utm_source=hs_email
KFF Health News: Newsom Promotes Affordable Insulin, But California’s Generic Label Off To A Slow Start
At a Walgreens in this city’s bustling Japantown neighborhood, pharmacist Margaret On stocks two boxes of long-acting insulin pens from California’s new prescription drug label, CalRx, emblazoned with the state’s iconic grizzly bear. Although she hasn’t dispensed any, On plans to keep them on hand. “It’s good to have if a patient comes in and doesn’t have health insurance,” she said. “Or just in case of emergencies.” (Hart, 8/17)
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario